# The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease

Study · id `cardio:ct-nct01260584` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01260584](<https://clinicaltrials.gov/study/NCT01260584>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01260584

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

## Technical summary

Registry record NCT01260584. Randomized; triple masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2011-09 (actual). Results posted on 2012-12-12.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 110 participants (enrolled count; ClinicalTrials.gov record NCT01260584, source copy `cardio:ctgov-nct01260584-2019-01-09`, retrieved 2026-10-26)
- Start date: 2010-11 (registry gives no type) (ClinicalTrials.gov record NCT01260584, source copy `cardio:ctgov-nct01260584-2019-01-09`, retrieved 2026-10-26)
- Primary completion: 2011-09 (actual) (ClinicalTrials.gov record NCT01260584, source copy `cardio:ctgov-nct01260584-2019-01-09`, retrieved 2026-10-26)
- Completion: 2011-09 (actual) (ClinicalTrials.gov record NCT01260584, source copy `cardio:ctgov-nct01260584-2019-01-09`, retrieved 2026-10-26)
- Results first posted: 2012-12-12 (ClinicalTrials.gov record NCT01260584, source copy `cardio:ctgov-nct01260584-2019-01-09`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01260584, source copy `cardio:ctgov-nct01260584-2019-01-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01260584-2019-01-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease
- Condition: Coronary Artery Disease
- Intervention (Drug): Prasugrel
- Intervention (Drug): Clopidogrel
- Lead sponsor: Daiichi Sankyo
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record: Prasugrel (`cardio:prasugrel`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)
- Registry lists this organization as the lead sponsor: Daiichi Sankyo (`cardio:org-daiichi-sankyo`)

## Provenance

Content hash: 7abbc656cc6c75b81857cf0908759ed8d2356ffa7f0110e78c543c9b7b1b3660
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
